SLU-PP-332 Capsules – 250mcg
SLU-PP-332 is a synthetic research peptide gaining attention for its potential role in cellular health and longevity studies. Moreover, it is being explored for its effects on mitochondrial function, oxidative stress regulation, and overall cellular resilience. For additional information, click here.
$125.00 / month
SLU-PP-332 is a synthetic small molecule studied in laboratory research for its interaction with the estrogen-related receptor (ERR) family, supplied by Advanced Peptide Institute at 99% purity for laboratory research use only. This 250mcg-per-capsule formulation is intended exclusively for qualified researchers studying mitochondrial-signaling pathways.
What is SLU-PP-332?
SLU-PP-332 is a synthetic small molecule characterized in published research as a pan-agonist of the estrogen-related receptor family (ERRα, ERRβ, and ERRγ), a group of nuclear receptors involved in regulating mitochondrial gene-expression programs. Researchers study SLU-PP-332’s interaction with these receptor pathways in cell-based laboratory models examining mitochondrial biogenesis and oxidative-metabolism signaling. Because the ERR family sits upstream of numerous mitochondrial gene networks, SLU-PP-332 is frequently referenced in laboratory literature exploring transcriptional control of cellular energy pathways at the receptor level. Advanced Peptide Institute’s SLU-PP-332 capsules are formulated to a consistent 250mcg dose per capsule and supplied strictly for laboratory and in vitro research applications.
Research Applications
SLU-PP-332 is commonly studied within receptor pharmacology research examining ERR-family agonism and its downstream interaction with mitochondrial gene-expression pathways. Researchers studying oxidative-metabolism signaling and mitochondrial biogenesis use SLU-PP-332 as a tool compound to probe ERR-receptor engagement in laboratory cell models. Skeletal-muscle-cell and cardiac-cell research models examining mitochondrial-density signaling pathways also reference SLU-PP-332’s ERR-agonist mechanism when studying transcriptional-network activity. Additional research contexts include structure-activity relationship studies of ERR-selective agonist compounds and pharmacokinetic research examining oral small-molecule absorption relevant to laboratory dosing models. Laboratory literature frequently compares SLU-PP-332’s pan-ERR agonist profile to isoform-selective reference compounds used in receptor-pharmacology assay panels. All such investigations are conducted exclusively within controlled laboratory environments.
Purity & Third-Party Testing
Advanced Peptide Institute SLU-PP-332 Capsules are supplied at 99% purity, independently verified through third-party High-Performance Liquid Chromatography (HPLC) testing and mass spectrometry analysis. This dual-verification process confirms both compound identity and exact purity level prior to release for research use. A Certificate of Analysis (COA) is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/, allowing researchers to confirm the specifications of the exact batch received.
Storage & Handling
Store SLU-PP-332 Capsules in a cool, dry place away from direct sunlight, heat, and moisture to preserve compound stability. Keep the container tightly sealed between uses and out of reach of children. Handle capsules in accordance with standard laboratory safety protocols and institutional research-handling guidelines.
Frequently Asked Questions
What purity is Advanced Peptide Institute SLU-PP-332 Capsules?
Advanced Peptide Institute SLU-PP-332 Capsules is supplied at 99% purity, verified by independent third-party HPLC testing and mass spectrometry. A Certificate of Analysis is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/.
How should SLU-PP-332 Capsules be stored?
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
What is SLU-PP-332 studied for?
SLU-PP-332 is studied in laboratory research for its interaction with estrogen-related receptor (ERR) pathways linked to mitochondrial gene expression.
Published laboratory research on SLU-PP-332 is indexed on PubMed.
Related Research Compounds: Limitless Capsules • BPC-157 Capsules – 500mcg • Browse all Capsules research compounds • Certificate of Analysis
For additional information, click here.
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.